No effect of diclofenac on the pharmacokinetics of cloxacillin

Pharmacology and Toxicology

Volumn 81, Issue 1, 1997, Pages 26-30

  Nergelius, Görel ^a   Vinge, Ellen ^a   Bengtsson, Hans Inge ^a   Björkman, Roland ^a   Grubb, Anders ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Medical Department   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CLOXACILLIN; DICLOFENAC; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EXCRETION; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; NORMAL HUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

EID: 0030746625     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb00026.x     Document Type: Article

References (30)

1. Ahnfelt, L. & G. Steen: Njurpåverkan vid infektionsprofylaktisk behandling med isoxazolylpenicilliner vid total höftledskirurgi. Poster at the Annual General Meeting of the Swedish Society of Medicine, 1992.
2. Bins, J. W. & H. Mattie: Saturation of the tubular excretion of β-lactam antibiotics. Br. J. Clin. Pharmacol. 1988, 25, 41-50.
3. Dubois, D. & E. F. Dubois: A formula to estimate the approximate surface area if height and weight be known. Arch. Intern. Med. 1916, 17, 863.
4. Ekman, I., B. Angelin, A. Hedberg & J. Sjövall: Pharmacokinetic comparison of flucloxacillin and cloxacillin. Astra 1990, data on file, report No. 806-06 Ac 001-1.
5. Grubb, A.: Zur empfindlichen und schnellen Klassifizierung der Proteinuri: Analyse einzelner Proteine im Urin. Diagnose und Labor 1992a, 42, 157-162.
6. Grubb, A.: Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin. Nephrol. 1992b, 38, suppl. 1, 20-27.
7. Hedström, S. Å. & C. H. Hybbinette: Nephrotoxicity in isoxazolyl-penicillin prophylaxis in hip surgery. Acta orthop. scand. 1988, 59, 144-147.
8. Hofmann, W., B. Rossmüller, W. G. Guder & H. H. Edel: A new strategy for characterizing proteinuria and haematuria from single pattern of defined proteins in urine. Eur. J. Clin. Chem. Clin. Biochem. 1992, 30, 707-712.
9. Isacson, J. & S. Collert: Renal impairment after high doses of dicloxacillin-prophylaxis in joint replacement surgery. Acta orthop. scand. 1984, 55, 407-410.
10. Joly, V. B. Pangon, N. Brion. J.-M. Vallois & C. Carbon: Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac. J. Pharmacol. Exp. Therap. 1988, 246, 695-700.
11. Kampmann, J., J. Mølholm-Hansen, K. Siersbæk-Nielsen & H. Laursen: Effect of some drugs on penicillin half-life in blood. Clin. Pharmacol. Therap. 1972, 13, 516-519.
12. Krutzén, E., S.-E. Bäck, I. Nilsson-Ehle & P. Nilsson-Ehle: Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J. Lab. Clin. Med. 1984, 104, 955-961.
13. TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver. Life Sci. 1993, 52,29-34.
14. Merle-Merlet, M., L. Bresler, F. Lokiec, C. Dopff, P. Boissel & J. B. Dureux: Effects of diclofenac on ceftriaxone pharmacokinetics in humans. Antimicrob. Agents Chemotherap. 1992, 36, 2331-2333.
15. Nergelius, G., E. Vinge, A. Grubb & L. Lidgren: Renal impairment after hip or knee arthroplasty. Acta orthop. scand. 1997, 68, 34-40.
16. Nierenberg, D. W.: Drug inhibition of penicillin tubular secretion: concordance between in vitro and clinical findings. J. Pharmacol. Exp. Therap. 1987, 240, 712-716.
17. Nordbring, F.: Is dicloxacillin nephrotoxic? Guest editorial. Acta orthop. scand. 1984, 55, 405-406.
18. Rowland, M. & T. N. Tozer: In: Clinical pharmacokinetics: concepts and applications, 2nd ed. Lea and Febiger, Pa, USA, 1989a, pp. 260-261.
19. Rowland, M. & T. N. Tozer: In: Clinical pharmacokinetics: concepts and applications, 2nd ed. Lea and Febiger, Pa, USA, 1989b, 247.
20. Shankel, S. W., D. C. Johnson, P. S. Clark, T. L. Shankel & W. M. O'Neil: Acute renal failure and glomerulopathy caused by non-steroidal anti-inflammatory drugs. Arch. Intern. Med. 1992, 152, 986-990.
21. Sioufi, A., J. Richard, P. Mangoni & J. Godbillon: Determination of diclofenac in plasma using a fully automated system combining liquid-solid extraction with liquid chromatography. J. Chromatogr. 1991, 565, 401-407.
22. Sladen, R. N.: Renal physiology. In: Anesthesia, 4th ed. Ed.: R. D. Miller. Churchill Livingston, New York, 1994, pp. 663-688.
23. Tencer, J., H. Thysell, K. Andersson & A. Grubb: Stability of albumin, protein HC, immunoglobulin G, κ- and λ-chain immunoreactivity, orosomucoid and α1-antitrypsin in urine stored at various conditions. Scand. J. Clin. Lab. Invest. 1994, 54, 199-206.
24. Thijssen, H. H. W.: Analysis of isoxazolyl penicillins and their metabolites in body fluids by high-performance liquid chromatography. J. Chromatogr. 1980, 183, 339-345.
25. Todd, P. A. & E. M. Sorkin: Diclofenac sodium: A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988, 35, 244-285.
26. Vinge, E., G. Nergelius, L. G. Nilsson & L. Lidgren: Pharmacokinetics of cloxacillin in patients undergoing hip or knee arthroplasty. Eur. J Clin. Pharmacol. 1997, in press.
27. Weinblatt, M. E.: Nonsteroidal anti-inflammatory drug toxicity: increased risk in the elderly. Scand. J. Rheumatol. 1991, Suppl. 9-17.
28. Whelton, A. & C. W. Hamilton: Non-steroidal anti-inflammatory drugs: effects on kidney function. J. Clin. Pharmacol. 1991, 31, 588-598.
29. Willis, J. V., M. J. Kendall, R. M. Flinn, D. P. Thornhill & P. G. Welling: The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur. J. Clin. Pharmacol. 1979, 16, 405-410.
30. Wood, A. J. J.: Drug interactions and adverse drug reactions. In: Drugs and anesthesia-pharmacology for anesthesiologists, 2nd ed. Eds.: M. Wood & A. J. J. Wood. Williams and Wilkinson, Md, USA, 1990, pp. 73-80.